Logo

LSBC Q3 Revenues Inch Over $1M Mark, Losses Narrow

Oct 22, 2003

NEW YORK, Oct. 22 (GenomeWeb News) – Large Scale Biology reported revenues of $1.2 million for the third quarter, compared to $0.7 million in the same period last year.

The Vacaville, Calif., company had a net loss of $4.3 million for the quarter, compared to $6.8 million for the third quarter of 2002.

LSBC's R&D expenses decreased to $2.8 million, from $4.5 million in the year-ago quarter.

At the end of the third quarter, the company had $11.3 million in cash and marketable securities.

Breaking News
The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.